Skip to main content
. 2020 Jan 13;115(2):281–293. doi: 10.14309/ajg.0000000000000516

Figure 1.

Figure 1.

Overview of patient flow through the study. The safety analysis set includes all patients who received ≥1 dose of treatment. The ITT analysis set includes all patients who met the study entry inclusion/exclusion criteria, were randomized, and received ≥1 dose of the study drug. b.i.d., twice daily; ITT, intention-to-treat; PRO, patient-reported outcome.